Rapport Therapeutics, Inc. (RAPP) SEC filings
RAPP SEC filings moved a median of +1.47% by the close. RAPP SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the RAPP overview →
36 measured RAPP SEC filing events.
Where these RAPP SEC filings landedvs 36 measured RAPP SEC filing reactions
| Middle 50% of RAPP SEC filing reactions | -1.61% to +5.48% |
|---|---|
| Median reaction (to close) | +1.47% |
| Measured reactions | 36 |
Point-in-time · zero look-ahead
Half of the 36 RAPP SEC filing events with a measured close landed between -1.61% and +5.48%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Rapport Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.51% | +2.44% | |
| Form 8-K Rapport Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +2.51% | +2.44% | |
| Form 8-K Rapport Therapeutics, For: Jun 10 | SEC filing · Form 8-K | -0.17% | +0.09% | |
| Form 10-Q Rapport Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.84% | +6.42% | |
| Form 8-K Rapport Therapeutics, For: May 07 | SEC filing · Form 8-K | -1.84% | +6.42% | |
| Form ARS Rapport Therapeutics, For: Dec 31 | SEC filing · Form ARS | -3.02% | -1.14% | |
| Form DEF 14A Rapport Therapeutics, For: Jun 10 | SEC filing · Form DEF | -3.02% | -1.14% | |
| Form DEFA14A Rapport Therapeutics, | SEC filing · Form DEFA14A | -3.02% | -1.14% | |
| Form 8-K Rapport Therapeutics, For: Apr 21 | SEC filing · Form 8-K | -1.00% | -1.60% | |
| Form 10-K Rapport Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.69% | +1.47% | |
| Form 8-K Rapport Therapeutics, For: Mar 10 | SEC filing · Form 8-K | -0.69% | +1.47% | |
| Form S-3ASR Rapport Therapeutics, | SEC filing · Form S-3ASR | -0.69% | +1.47% | |
| Form S-8 Rapport Therapeutics, | SEC filing · Form S-8 | -0.69% | +1.47% | |
| Form 8-K Rapport Therapeutics, For: Jan 07 | SEC filing · Form 8-K | -0.59% | +8.89% | |
| Form 10-Q Rapport Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.38% | -4.30% | |
| Form 8-K Rapport Therapeutics, For: Nov 06 | SEC filing · Form 8-K | -0.38% | -4.30% | |
| Form 8-K Rapport Therapeutics, For: Sep 09 | SEC filing · Form 8-K | +1.66% | +3.80% | |
| Form 8-K Rapport Therapeutics, For: Sep 08 | SEC filing · Form 8-K | +2.22% | -17.90% | |
| Form 10-Q Rapport Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +5.48% | |
| Form 8-K Rapport Therapeutics, For: Aug 07 | SEC filing · Form 8-K | +0.00% | +5.48% | |
| Form EFFECT Rapport Therapeutics, | SEC filing · Form EFFECT | +1.07% | +9.54% | |
| Form S-3 Rapport Therapeutics, | SEC filing · Form S-3 | +2.26% | +2.35% | |
| Form 8-K Rapport Therapeutics, For: Jun 17 | SEC filing · Form 8-K | +1.71% | -1.62% | |
| Form 8-K Rapport Therapeutics, For: Jun 02 | SEC filing · Form 8-K | -2.13% | +26.97% | |
| Form 10-Q Rapport Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +4.21% | |
| Form 8-K Rapport Therapeutics, For: May 08 | SEC filing · Form 8-K | +0.00% | +4.21% | |
| Form ARS Rapport Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.18% | -2.12% | |
| Form DEF 14A Rapport Therapeutics, For: Jun 17 | SEC filing · Form DEF | -0.18% | -2.12% | |
| Form DEFA14A Rapport Therapeutics, | SEC filing · Form DEFA14A | -0.18% | -2.12% | |
| Form 10-K Rapport Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +1.45% | +8.34% | |
| Form 8-K Rapport Therapeutics, For: Mar 11 | SEC filing · Form 8-K | +1.45% | +8.34% | |
| Form S-8 Rapport Therapeutics, | SEC filing · Form S-8 | +1.45% | +8.34% | |
| Form 8-K Rapport Therapeutics, For: Mar 03 | SEC filing · Form 8-K | -1.92% | -25.91% | |
| Form 8-K Rapport Therapeutics, For: Jan 09 | SEC filing · Form 8-K | -8.56% | -10.13% | |
| Form 10-Q Rapport Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.22% | -0.41% | |
| Form 8-K Rapport Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +1.22% | -0.41% |
Keep exploring
More RAPP: earnings → · analyst actions → · RAPP overview →